Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer

By Nijman H.W.   Kenemans P.   Poort-Keesom R.J.J.   Verstraeten R.A.   Mensdorff-Pouilly S.   Verheijen R.H.M.   Melief C.J.M.   Hilgers J.   Meijer C.J.L.M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 83, Iss. 2, 1999-04 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite

Neoadjuvant chemotherapy in the management of advanced epithelial ovarian cancer

By Hou June Y   Schwartz Peter E  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 3, 2007-05 ,pp. : 321-329

Informa Healthcare

Access to resources Recommend Favorite

p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis

By Bremer G.L.   Tieboschb A.T.M.G.   van der Putten H.W.H.M.   de Haan J.   Arends J.-W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 63, Iss. 1, 1995-11 ,pp. : 55-59

Elsevier

Access to resources Recommend Favorite

The combination of p53 and age predict cancer specific death in advanced stage (FIGO Ic-IV) of endometrial carcinoma of endometrioid type An immunohistochemical examination of growth fraction: Ki-67, MIB-1 and PC10; suppressor oncogene protein: p53; oncogene protein: p185 and age, hormone treatment, stage, and histologic grade

By Nielsen A.L.   Nyholm H.C.J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 70, Iss. 1, 1996-12 ,pp. : 79-85

Elsevier

Access to resources Recommend Favorite

Neuroendocrine small-cell cervical carcinoma

By Appetecchia M.   Benevolo M.   Mariani L.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 96, Iss. 1, 2001-05 ,pp. : 128-131

Elsevier

Access to resources Recommend Favorite